Report Materials
In a follow-up review of Georgia's Medicaid drug rebate program, we found that, as of June 30, 2006, the Georgia Department of Community Health (the State agency) did not implement two of the four recommendations from our previous drug rebate review related to the collection process and write-offs. As a result, the State agency could not determine exactly what amount in uncollected drug rebates to pursue from the manufacturers, and it was unable to correctly identify drug rebate amounts due to the State agency from the various manufacturers.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.